Maze Therapeutics, Inc. (MAZE)
NASDAQ: MAZE · Real-Time Price · USD
41.71
-0.89 (-2.09%)
Dec 5, 2025, 4:00 PM EST - Market closed
Maze Therapeutics Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for Maze Therapeutics stock have an average target of 41, with a low estimate of 28 and a high estimate of 60. The average target predicts a decrease of -1.70% from the current stock price of 41.71.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Maze Therapeutics stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 3 | 3 | 3 | 3 |
| Buy | 3 | 3 | 3 | 3 | 3 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 6 | 6 | 6 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Initiates $55 | Buy | Initiates | $55 | +31.86% | Dec 4, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $50 → $60 | Strong Buy | Maintains | $50 → $60 | +43.85% | Dec 3, 2025 |
| Wedbush | Wedbush | Buy Maintains $35 → $36 | Buy | Maintains | $35 → $36 | -13.69% | Nov 7, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $27 → $37 | Buy | Maintains | $27 → $37 | -11.29% | Sep 29, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | +19.88% | Sep 18, 2025 |
Financial Forecast
Revenue This Year
n/a
from 167.50M
Revenue Next Year
1.53M
EPS This Year
-3.27
from 1.25
EPS Next Year
-3.15
from -3.27
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | n/a | 12.6M | ||||
| Avg | n/a | 1.5M | ||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -3.21 | -2.71 | ||||
| Avg | -3.27 | -3.15 | ||||
| Low | -3.38 | -3.96 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.